LOCOREGIONAL RECURRENCE
Clinical trials for LOCOREGIONAL RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONAL RECURRENCE trials appear
Sign up with your email to follow new studies for LOCOREGIONAL RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted pill stop breast Cancer's return? major trial launches
Disease control Recruiting nowThis phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy can prevent breast cancer from coming back in people with a specific type of breast cancer (HR+/HER2-) who have already had a local recurrence. About 290 participants will be randoml…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for breast cancer patients: drug combo aims to stop recurrence
Disease control Recruiting nowThis study tests whether adding the drug ribociclib to standard hormone therapy can prevent breast cancer from coming back in people whose cancer has already returned in the same area. About 200 adults with hormone receptor-positive, HER2-negative breast cancer will take part. Th…
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New study aims to improve treatment for breast cancer recurrence
Knowledge-focused Recruiting nowThis study follows 500 breast cancer patients whose cancer has returned in the same area. They will receive radiation again, with or without heat therapy (hyperthermia). The goal is to compare side effects, quality of life, and survival over five years to help doctors and patient…
Matched conditions: LOCOREGIONAL RECURRENCE
Sponsor: Amsterdam UMC, location VUmc • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC